Highest-materiality recent filing
Abacus posts record Q2: rev $73M (+30% YoY), raises capital deploy guide to $150-175M/qtr
Q2 2026 revenue $73.0M (+30% YoY); Life Solutions grew 38.3%; adjusted net income $27.1M above guidance.
Abacus Global Management authorizes $100M share repurchase program
Board authorized $100M share repurchase program, effective Aug 17, 2026, through May 6, 2028.
Q2 total revenue $73.0M (+30% YoY); GAAP net income $6.6M (-63% YoY) on strategic expenses; adjusted net income $27.1M (+24% YoY).
Abacus Global Management adds $75M incremental term loans; director resigns
Incremental term loans of $75M added, raising total credit facility to $225M.
Abacus launches LifeARC™ AI lifespan platform; $50M Manning & Napier partnership live
Launched LifeARC™, an AI-powered lifespan modeling platform using 20 years of proprietary data to personalize retirement planning.
Abacus Global Management shareholders approve 2026 LTIP, re-elect directors
2026 LTIP approved with 62.1M for, 8.5M against; authorizes 17M new shares plus prior plan carryover and annual evergreen up to 5% of outstanding.
Abacus Global completes $52.9M minority investment in Manning & Napier, forms strategic alliance
Minority equity investment of ~$53M from Abacus in Manning & Napier; includes Strategic Alliance Agreement.
Q1 revenue $59.4M +35% YoY; raises FY adj. net income guidance to $100-106M
Q1 revenue $59.4M (+35% YoY); GAAP net income $7.3M (+59%); operating cash flow $91.7M vs -$61.6M.
Abacus Global Management appoints new CAO and CIO; McCauley steps down as CAO but remains CFO/COO
William McCauley resigned as CAO effective April 17, 2026; remains CFO, COO, and director.
Abacus Global switches auditor to KPMG, names McCauley COO, sets $192M stretch ANI target
Dismissed Grant Thornton, engaged KPMG as auditor effective March 16, 2026; no disagreements or reportable events.
Q4 revenue $71.9M (+116% YoY); full-year revenue $235.2M (+110% YoY), beating consensus by 20%.
Abacus Global announces $20M share repurchase program through May 2027
Board authorized up to $20M of common stock repurchases, effective immediately until May 6, 2027.
Abacus raises FY adjusted net income guidance to $80-84M, completes $50M securitized note
Full-year 2025 adjusted net income guidance raised to $80-84M, representing 72-81% YoY growth.
Abacus Global Management transfers listing from Nasdaq to NYSE; new symbols ABX and ABXL
Voluntary transfer of common stock and 2028 notes from Nasdaq to NYSE completed; Nasdaq trading ceased Dec 29, 2025.
Abacus Global Management to transfer listing from Nasdaq to NYSE; new symbols ABX, ABXL
Common stock will trade on NYSE as ABX starting Dec 30, 2025; Nasdaq trading as ABL ends Dec 29.
Abacus Global Management declares inaugural $0.20 annual dividend; payable Dec 17, 2025
Annual cash dividend of $0.20 per share; record date Dec 2, 2025; payable Dec 17, 2025.
Abacus Global declares $0.20 annual dividend and authorizes $10M share buyback
Board declares annual cash dividend of $0.20 per share, payable Dec 17, 2025 to holders of record Dec 2, 2025.
Abacus Q3 revenue $63M (+124% YoY); adj. net income $23.6M (+60%); raises 2025 outlook
Revenue $63.0M (+124% YoY); adj. net income $23.6M (+60%) and adj. EBITDA $37.9M (+127%).
Abacus raises FY 2025 adjusted net income guidance to $74M-$80M, sees 59-72% growth
Q2 revenue and adjusted net income nearly doubled YoY; strong performance cited.
Abacus Q2 revenue nearly doubles to $56.2M, raises full-year adjusted net income outlook
Q2 total revenue $56.2M (up 93% YoY); GAAP net income $17.6M vs $0.7M prior year.
Issued 4,183,160 shares of common stock in exchange for warrants tendered in the Offer.
Abacus completes warrant exchange; 88% tendered, remaining exchanged at 0.207 shares
18,188,277 warrants (~88% of total) validly tendered; holders receive 0.23 shares per warrant.
Abacus Global Management launches warrant exchange offer for up to 4.74M shares
Offers 0.23 shares of common stock per warrant (public and private); up to 4,743,381 shares issuable.
Abacus Global Management to exchange warrants for 0.23 common shares per warrant
Offer to exchange each outstanding warrant for 0.23 shares of common stock.
Abacus Global Management re-elects three Class II directors, ratifies Grant Thornton auditor
Stockholders re-elected Cornelis Michiel van Katwijk, Mary Beth Schulte, and Karla Radka as Class II directors for three-year terms.
Abacus Global Management approves $20M stock repurchase program over 18 months
Board authorized a $20 million share repurchase program on June 5, 2025; effective for 18 months.
CEO Jay Jackson salary raised to $500,000; CFO William McCauley to $450,000; three Presidents to $350,000 each.
Abacus Global Q1 revenue $44.1M (2x YoY); adj. net income up 158% to $17.3M
Total revenue doubled to $44.1M vs $21.5M YoY; GAAP net income $4.6M vs loss $1.3M.
Abacus Global Management announces $15M stock repurchase program over 18 months
Board of Directors approved a $15 million stock repurchase program on April 9, 2025.
Abacus Global amends vesting of 500,000 RSUs granted to CFO; three equal tranches
CFO William H. McCauley, Jr.'s 500,000 RSUs now vest in three equal tranches on July 3 of 2024, 2025, and 2026.
Abacus grants 125,000 RSUs to CFO Mr. McCauley under 2024 equity plan
Grant of 125,000 restricted stock units to CFO McCauley on March 27, 2025.
Abacus Q4 revenue $33.2M (+40% YoY); FY adj net income $46.5M; sees 2025 adj NI $70-78M
Q4 total revenue $33.2M (+40% YoY); policy originations 214, capital deployment $96.6M (+41% vs $68.3M prior year).
Abacus issues $5M Series A Convertible Preferred to acquire interest in Dynasty Financial
Issued 5,000 shares of Series A Convertible Preferred to Dynasty Financial Holdings in exchange for 400,000 Class A Interests of Dynasty.
Abacus Life changes name to Abacus Global Management; no shareholder vote needed
Name change effective Feb 27, 2025 via Certificate of Amendment filed with Delaware.
Abacus Life grants 125,000 RSUs to CFO William McCauley under new award form
CFO William H. McCauley, Jr. granted 125,000 restricted stock units under the 2024 LTI Plan.
Abacus Life closes $150M senior secured term loan with Sagard and Värde
Initial $100M drawn at close; additional $50M delayed draw available subject to conditions.
Consideration: 9,213,735 Abacus common shares and $72.7M principal of 9.875% Senior Notes due 2028.
Abacus Life completes acquisition of FCF Advisors (~$800M AUM)
Acquisition closed December 2, 2024; FCF Advisors is a New York-based asset manager and index provider.
Abacus Life closes $100M public offering (12.5M shares at $8.00); $80M net to company
Offering of 12.5M shares: 10M primary (company) + 2.5M secondary (selling stockholders) at $8.00/share.
Abacus Life offers 12.5M shares in public offering; CEO's restricted shares accelerated
Offering of 12.5M shares (10M primary, 2.5M secondary) with 30-day option for up to 1.5M additional shares.
Abacus Life Q3 rev $28.1M (+33%), adj net income $14.9M (+65%); M&A on track
Total revenue $28.1M (+33% YoY); GAAP net loss $5.1M due to non-cash warrant liability of $7.8M.
Abacus Life prelim Q3 revenue $26-28M (+23-33% YoY); adj. EBITDA $14-16M (+30-48% YoY)
Total revenue prelim $26-28M vs $21.2M in Q3 2023, 23-33% YoY growth.
Abacus Life Q2 revenue doubles to $29.1M; announces two acquisitions adding ~$2.6B AUM
Total revenue $29.1M (up >100% YoY); GAAP net income $0.8M vs $6.8M; adjusted net income $11.8M (+75%).
Abacus Life awards $200k special cash bonus to CFO William McCauley
Compensation Committee approved $200,000 special cash bonus to CFO William H. McCauley, Jr.
Abacus Life to acquire FCF Advisors, adding ~$600M in AUM
Acquisition of FCF Advisors, a free cash flow-focused asset manager with ~$600M AUM.
Abacus Life acquires Carlisle Management for ~$200M, adding up to $2B AUM
Purchase price ~$200M: 62.3% in Abacus common stock at $13.05/sh (9.3M shares) and 37.7% in 9.875% senior notes.
Abacus Life expects Q2 revenue $28-30M (146-163% YoY growth); Adj. EBITDA $15-17M
Total revenue guided $28-30M for Q2 2024, up 146-163% YoY.
Abacus Life closes $92M public offering of 11.5M common shares at $8.00
Gross proceeds ~$92M from 10M base + 1.5M option shares at $8.00/share.
Adam Gusky and Sean McNealy re-elected as Class I directors with ~49.4M votes for, ~33.5K withheld, 1.4M broker non-votes.
Abacus Life launches underwritten offering of 10M common shares
10,000,000 shares offered; underwriters have 30-day option for up to 1,500,000 additional shares.
On June 30, 2026, Sean McNealy notified the Company of his decision to resign from his role as a director of the Company, effective June 30, 2026, in connection with his planned retirement.
Gary L. Hagerman, Jr. and Kim Pegula each resigned as a director of the Company.
Effective as of September 10, 2021, the Board appointed Thomas A. Lopus as a director of the Company to fill the vacancy on the Board that resulted from the previously report passing of Mr. Sobol.
Gary L. Hagerman, Jr. and Kim Pegula each resigned as a director of the Company.
Max materiality 0.85 · Median 0.65 · Most common event other_material